Áttétes emlőrák: vizsgálatok itt: Egyesült Királyság
36 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Where
- Brighton, Cardiff, Guildford, London, Taunton
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT07085767 · EU 2025-522873-12-00 - No phaseTaking peopleEORTC Metastatic Breast Cancer Module Development
- Where
- Leeds, Rickmansworth
- Életkor
- 18 év and over
- People
- 568 worldwide
- Run by
- University of Leeds
See details and how to joinNCT07806266 - 1/2. fázisTaking peopleStudy of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Where
- London
- Életkor
- 18 év to 100 év
- People
- 280 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00 - 3. fázisTaking peopleElacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- Where
- Edinburgh, London, Oxford, Surrey Quays, Truro, Waterlooville
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- MedSIR
See details and how to joinNCT06382948 · EU 2024-512926-27-00 - No phaseFut, nem toborozAURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
- Where
- Birmingham, Bristol, Cardiff, Dundee, Edinburgh, Glasgow, Manchester, Nottingham, Swansea, Truro, Yeovil
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Jules Bordet Institute
See details and how to joinNCT02102165 - No phaseTaking peopleHER2+ CNS Surveillance
- Where
- Liverpool
- Életkor
- 16 év and over
- People
- 69
- Run by
- The Clatterbridge Cancer Centre NHS Foundation Trust
See details and how to joinNCT07748598 - 2. fázisTaking peopleSafety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
- Where
- Bath, Lancaster, London
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- MedSIR
See details and how to joinNCT06486883 · EU 2024-512360-55-00 - 1/2. fázisTaking peoplePhase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
- Where
- Liverpool, London, Manchester
- Életkor
- 18 év and over
- People
- 95 worldwide
- Run by
- Ellipses Pharma
See details and how to joinNCT05573126 - 2. fázisTaking peopleInvestigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
- Where
- London
- Életkor
- 18 év to 64 év
- People
- 140 worldwide
- Run by
- Queen Mary University of London
See details and how to joinNCT06954480 · EU 2024-519913-76-00 - No phaseTaking peopleFeasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution
- Where
- London
- Életkor
- 18 év and over
- People
- 200
- Run by
- Royal Marsden NHS Foundation Trust
See details and how to joinNCT07084571 - 1/2. fázisTaking peoplePhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
- Where
- Newcastle upon Tyne
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- One-carbon Therapeutics AB
See details and how to joinNCT07151040 · EU 2024-519639-40-00